February 5, 2014
The promise of Google's glucose-sensing contact lens is non-invasive continuous glucose monitoring: that rather than having to prick themselves with lancets several times a day, the nation's 26 million people with diabetes could take their readings on their phone via passively collected tears.
If that sounds too good to be true to you, you're not alone. A number of voices in the diabetes care...
November 16, 2009
CGM start-up raises $3M: Echo Therapeutics, which is developing a needle-free, non-invasive, wireless, transdermal continuous glucose monitoring system and and a system for transdermal drug delivery, raised $3 million in additional capital by selling common stock to accredited and institutional investors. More
Medtronic points to studies lauding CGM: “It’s very exciting to see the evidence unfold...